Categories: News

ResMed Announces Participation in the Morgan Stanley 19th Annual Global Healthcare Conference

SAN DIEGO, Sept. 02, 2021 (GLOBE NEWSWIRE) — ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference on Thursday, September 9, 2021, beginning at approximately 1:15 p.m. (Eastern Daylight Time) via video webcast.

More information about this event, including access to the live webcast, may be accessed by visiting https://investor.resmed.com. The webcast replay will be available approximately one hour after the live webcast ends and will be accessible through December 8, 2021, following the conference.

About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.

For investors For media
Amy Wakeham Jayme Rubenstein
+1 858.836.5000 +1 858.836.6798
investorrelations@resmed.com news@resmed.com

Staff

Recent Posts

Kandu Health and Neurolutions Merge to Form Kandu, Inc., a New Leader in Stroke Recovery

Kandu, Inc. Announces $30 Million Financing to Advance Stroke Recovery and Rehabilitation VAN NUYS, Calif.--(BUSINESS…

1 hour ago

Rapid Dose Therapeutics Provides Update on the Clinical Trial Development and the Commitment to NFL Funded Cannabinoid Research

Burlington, Ontario--(Newsfile Corp. - April 8, 2025) -  Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or…

1 hour ago

AMPS Raises the Bar on RBP with PriceDynamix: Delivering Elevated Member Advocacy, Smarter Savings, and Greater Accountability

PHOENIX, April 08, 2025 (GLOBE NEWSWIRE) -- The healthcare industry has outgrown the outdated and…

1 hour ago

Psyence BioMed Signs LOI with Southern Star Research to Expand Phase IIb Clinical Trial in Australia

New partnership strengthens Psyence BioMed's global clinical trial capabilities, accelerating the development of psilocybin-assisted therapy…

3 hours ago

SHINE and Sumitomo Corporation of Americas Announce Partnership to Expand Medical Isotope and Fusion Technology Distribution in Asian Markets

Strategic alliance set to strengthen supply chains for medical isotopes, industrial applications, and fusion technologies…

4 hours ago

Xeltis successfully passes evaluation phase for €10million investment from European Innovation Council

Xeltis is one of only seven companies to successfully pass evaluation phase of EIC Strategic…

4 hours ago